Investment Company, Inc. Awm Net Worth

The estimated Net Worth of Investment Company, Inc. Awm is at least $44.9 million dollars as of 15 April 2024. Investment Awm owns over 1,000 units of G Medical Innovations stock worth over $259,927 and over the last 10 years Investment sold GMVD stock worth over $44,590,583.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Investment Awm GMVD stock SEC Form 4 insiders trading

Investment has made over 138 trades of the G Medical Innovations stock since 2015, according to the Form 4 filled with the SEC. Most recently Investment sold 1,000 units of GMVD stock worth $1,700 on 15 April 2024.

The largest trade Investment's ever made was selling 2,250,000 units of G Medical Innovations stock on 18 May 2015 worth over $5,017,500. On average, Investment trades about 117,704 units every 23 days since 2015. As of 15 April 2024 Investment still owns at least 1,444,037 units of G Medical Innovations stock.

You can see the complete history of Investment Awm stock trades at the bottom of the page.

What's Investment Awm's mailing address?

Investment's mailing address filed with the SEC is 527 MADISON AVENUE, SUITE 2600, NEW YORK, NY, 10022.

Insiders trading at G Medical Innovations

Over the last 2 years, insiders at G Medical Innovations have traded over $663,750 worth of G Medical Innovations stock. The most active insiders traders include Investment Company, Inc. Awm. On average, G Medical Innovations executives and independent directors trade stock every 0 days with the average trade being worth of $132,750. The most recent stock trade was executed by Investment Company, Inc. Awm on 31 March 2023, trading 737,500 units of GMVD stock currently worth $663,750.

What does G Medical Innovations do?

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel.

Complete history of Investment Awm stock trades at Broadwind Inc, Cellectar Biosciences Inc, Destination XL Inc, Emcore, Ideal Power Inc, IZEA Worldwide Inc, Lightbridge Corp, PFSWEB Inc, Recro Pharma Inc, CPI Aerostructures Inc, EMagin Corp, InfuSystem Inc, Intellicheck Inc, LiqTech International Inc, NTN Buzztime Inc, OptimizeRx Corp, Genasys Inc, urban-gro et G Medical Innovations

G Medical Innovations executives and stock owners

G Medical Innovations executives and other stock owners filed with the SEC include:

• Dr. Yacov Geva,
  Pres, CEO, MD & Exec. Director
• Brett Tucker,
  Company Sec.
• Dror Nuriel-Roth,
  Exec. VP of US Operations
• Oded Shahar,
  Sr. Investment Banker and Sr. VP of Merger & Acquisition
• Benny Tal,
  VP of R&D and CTO
• Kobi Ben-Efraim,
  Chief Financial Officer
• Investment Company, Inc. Awm,
  10% owner